About: Erlotinib versus carboplatin and paclitaxel in advanced lepidic adenocarcinoma: IFCT-0504.   Goto Sponge  NotDistinct  Permalink

An Entity of Type : owl:Thing, within Data Space : data.idref.fr associated with source document(s)

AttributesValues
Author
Bibliographic Citation
  • Cadranel Jacques, Gervais Radj, Merle Patrick, Moro-Sibilot Denis, Westeel Virginie, Bigay-Game Laurence, Quoix Elisabeth, Friard Sylvie, Barlesi Fabrice, Lethrosne Claire, Moreau Lionel, Monnet Isabelle, Salaün Mathieu, Oliviero Gérard, Souquet Pierre-Jean, Antoine Martine, Langlais Alexandra, Morin Franck, Wislez Marie, Zalcman Gérard. Erlotinib versus carboplatin and paclitaxel in advanced lepidic adenocarcinoma: IFCT-0504. European Respiratory Journal, European Respiratory Society, 2015, 46 (5), pp.1440-1450. ⟨10.1183/13993003.02358-2014⟩
Title
  • Erlotinib versus carboplatin and paclitaxel in advanced lepidic adenocarcinoma: IFCT-0504.
dc:date
  • 2015
Faceted Search & Find service v1.13.91 as of Aug 16 2018


Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software